Insider Transactions Reported by 13 Insiders of Liminatus Pharma, Inc.

Symbol
LIMN, LIMNW on Nasdaq
Location
Cerritos, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Liminatus Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Iris Acquisition Holdings LLC 10%+ Owner $45,885,000 30 Apr 2025
Valetudo Therapeutics LLC 10%+ Owner $32,204,299 30 Apr 2025
KH Feelux Co., Ltd 10%+ Owner $20,880,000 30 Apr 2025
Byong C. Yoo Chief Science Officer 30 Apr 2025
Scott Dam Chief Financial Officer 30 Apr 2025
Chris Kim Chief Executive Officer, Director, 10%+ Owner 30 Apr 2025
Ji Yeon Baek Director 30 Apr 2025
Eun Sook Lee Director 30 Apr 2025
Beom K. Choi Chief Technology Officer 30 Apr 2025
Nicholas Fernandez Director 30 Apr 2025
Sang-Jin Daniel Lee Head of Research & Development 30 Apr 2025
II Philip Wayne Lemons Director 10 Jul 2025
Richard JaiHwan Baek Director 10 Jul 2025

Recent Insider Transactions by Companies or Individuals for Liminatus Pharma, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Iris Acquisition Holdings LLC LIMN Common Stock 0 6,900,000 30 Apr 2025 Direct
KH Feelux Co., Ltd LIMN Common Stock 0 4,000,000 30 Apr 2025 Direct
Valetudo Therapeutics LLC LIMN Common Stock, par value $0.0001 per share 0 6,169,406 30 Apr 2025 Direct
Chris Kim LIMN Common Stock, par value $0.0001 per share 0 6,169,406 30 Apr 2025 See Footnote
* An asterisk sign (*) next to the price indicates that the price is likely invalid.